Skip to main content
AkademIndex

Products

For developers

AkademBaseOpen API for the ecosystem
← Back to work

Works citing this work

1 works

  1. Placebo-Controlled Dose-Ranging Phase 2 Study of Subcutaneously Administered LHRH Antagonist Cetrorelix in Patients with Symptomatic Benign Prostatic Hyperplasia

    F.M.J. Debruyne, A A Gres, D. Arustamov

    ArticleUrinary Bladder and Prostate ResearchEuropean Urology20081 citations
    ABI